hotspot -WSS

hotspot

author：entertainment 2025-09-27 22:47:29 - browse：22

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： As demand for Covid shots wanes, Moderna seeks its next success

focus

WSS

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Hepatitis C has a cure — but many Americans still lack access to it

Hepatitis C has a cure — but many Americans still lack access to it

Manchin plays down potential 3rd

Tori Bowie and the unacceptable rates of Black maternal death

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

focus

hotspot

focus

New air purifier tech could be key to improving indoor air quality

Study: Hearing aids may slow cognitive decline in those at risk

Trump demands the U.S. pay no more for drugs than other countries … again

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

State Dept. review finds Biden bears some blame for Afghanistan failures

What we know about the American soldier detained in North Korea

Medicare details structure of new drug price negotiation program

A Theranos scientist

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A strong 6.5

focus

More hospitals are billing patients as online messages surge

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Wildfire smoke exposes gaps in outdoor worker protections

House passes resolution saying Israel isn't a 'racist or apartheid state'

Lack of darker skin in textbooks, journals harms patients of color

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

focus

knowledge

focus

hotspot